Skip to main content
Premium Trial:

Request an Annual Quote

DoubleTwist Lays Off 20, Promotes Two in Attempt to Streamline Operations

NEW YORK, March 6 – DoubleTwist spokeswoman Nicole Litchfield said Tuesday the company laid off “around 20 people” last week, approximately 10 percent of its staff.

Litchfield said the layoffs were “part of a reorganization to gain efficiency after hiring about 120 people last year.”    

The layoffs were applied equally across the company, Litchfield said. DoubleTwist does not plan any further consolidations.

As part of the reorganization, Robert Williamson, formerly COO, was promoted to president and COO, and Edward Kiruluta, formerly vice president of R&D, was promoted to CTO.    

DoubleTwist filed for an IPO in September, but has since delayed its plans. “We have not withdrawn our IPO,” Litchfield said, “but naturally we're examining all of our options in light of the current financial markets.” 

The layoffs follow closely behind NetGenics’ decision to slash its workforce by 30 percent under similar circumstances.

According to DoubleTwist’s most recent filing with the SEC, an amended S-1 filed November 9, the company’s cash, cash equivalents, and marketable securities were $24.1 million as of September 30.     

For the last nine months of 2000, the last period for which information is available, DoubleTwist’s revenues totaled $4.8 million.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.